Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1b Multicenter, Randomized, Single-Masked, Sham-Controlled Study of the Safety and Tolerability of ONL1204 Ophthalmic Solution in Patients with Progressing Open Angle Glaucoma

Next Previous
Trial Profile

A Phase 1b Multicenter, Randomized, Single-Masked, Sham-Controlled Study of the Safety and Tolerability of ONL1204 Ophthalmic Solution in Patients with Progressing Open Angle Glaucoma

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 06 Feb 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ONL 1204 (Primary)
  • Indications Open-angle glaucoma
  • Focus Adverse reactions
  • Sponsors ONL Therapeutics

Most Recent Events

  • 04 Feb 2025 According to an ONL Therapeutics media release, company will present clinical data from this study at Glaucoma Innovation Summit at the American Glaucoma Society (AGS) 2025 Annual Meeting, February 26 - March 2, 2025, at the Omni Shoreham Hotel in Washington, D.C.
  • 29 Oct 2024 Status changed from active, no longer recruiting to completed.
  • 13 Jul 2023 Planned End Date changed from 1 Sep 2023 to 1 Oct 2024.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top